Theralase Technologies Inc (TLTFF) Stock Price & News

TLTFF:OTCMKTS

Theralase Technologies Inc

$0.13

-2.47%

(-0.0034) 1D

Sep 18, 4:00:00 PM GMT-4 · USD

All symbols

YTD

MAX

	Symbol	Price	Change	% Change

Generating top insights for TLTFF...

Open

$0.13

High

$0.13

Low

$0.13

Mkt. cap

47.56M

Avg. vol.

202.99K

Volume

114.50K

52-wk high

$0.31

52-wk low

$0.10

Beta

1.02

Shares outstanding

310.48M

No. of employees

Open

$0.13

High

$0.13

Low

$0.13

Mkt. cap

47.56M

Avg. vol.

202.99K

Volume

114.50K

52-wk high

$0.31

52-wk low

$0.10

Beta

1.02

Shares outstanding

310.48M

No. of employees

Related stocks

OZSC

Ozop Energy Solutions Inc

$0.014

-7.81%

MRES

Institute of Biomedical Research Ord Shs

$0.0020

+8.11%

EMED

Electromedical Technologies Inc

News stories

From web sources and news partners

TipRanks

17 hours ago

Theralase Narrows Loss and Expands Bladder Cancer Trial with Ferring

FinanzNachrichten.de

18 hours ago

Theralase Technologies Inc.: Theralase(R) Releases Q2 2026 Financial Statements

TMX Newsfile

18 hours ago

Correcting and Replacing: Theralase(R) Releases Q2 2026 Financial Statements

Kalkine Media

18 hours ago

Theralase Technologies Announces Q2 2026 Financial Results, Ruvidar® Phase II Bladder Cancer Data, and Upcoming Combination Study with Adstiladrin

About Theralase Technologies Inc

CEO-

Employees20

Founded1989

HeadquartersToronto, Ontario, Canada

SectorMedical device

Websitetheralase.com

All values in CAD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	279.64K	225.90K	132.63K	164.29K
Cost of goods sold	120.78K	9.59K	68.25K	78.73K
Cost of revenue	120.78K	9.59K	68.25K	78.73K
Research and development expenses	656.09K	335.90K	564.72K	536.40K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	522.76K	572.92K	530.09K	612.52K
Operating expense	1.18M	908.82K	1.09M	1.15M
Total operating expenses	1.30M	918.42K	1.16M	1.23M
Operating income	-1.02M	-692.52K	-1.03M	-1.06M
Other non operating income	-	-	1.00	-
EBT including unusual items	-1.01M	-685.67K	-1.03M	-1.06M
EBT excluding unusual items	-1.01M	-685.67K	-1.03M	-1.06M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-1.01M	-685.67K	-1.03M	-1.06M
Net profit margin	-361.86%	-303.54%	-777.92%	-646.49%
Earnings per share	-	-	-	-
Interest and investment income	16.94K	27.58K	19.33K	19.86K
Interest expense	-4.14K	-28.35K	-14.28K	-13.36K
Net interest expenses	12.80K	-769.00	5.06K	6.50K
Depreciation and amortization charges	-	-	-	-
EBITDA	-977.41K	-643.35K	-994.73K	-1.04M
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything